… after neoadjuvant chemotherapy (NACT) are still under investigation. The aim of this study
was to compare CA125 and HE4 … Serum HE4 and CA125 samples were taken at the time of …

… In the case of CA125 and HE4, their kinetics during NACT in … the kinetics of serological CA125
and HE4 during CO treatment … patients receiving neoadjuvant chemotherapy for advanced …

… of HE4 before and after neoadjuvant chemotherapy could predict optimal interval debulking
surgery. Serum HE4 was superior to CA125 in … ) of HE4 in neoadjuvant chemotherapy could …

… HE4 and CA125 changes during NACT did not correlate with the … the HE4 profile in the
neoadjuvant chemotherapy setting and the first study that compares the HE4 profile to CA125 and …

… , HE4, and to compare it with CA125 in predicting optimal cytoreduction and response to
chemotherapy… multiple sera harvested during neoadjuvant chemotherapy (NAC) were included. …

… of CA 125 above 2000 U/ml and qualified as eligible for the neoadjuvant chemotherapy gain
… coefficient of CA 125 after two courses of the neoadjuvant chemotherapy has statistically …

… the serum levels of CA125 and HE4 before each chemotherapy cycle together with their …
for patients who underwent neoadjuvant chemotherapy and the day before each cycle. …

… CA-125 or HE4 levels during NACT and residual disease or recurrence. The normalization
of HE4 – but not CA-125 … the utility of HE4 changes during neoadjuvant chemotherapy (NACT…

… the 3rd cycle of neoadjuvant chemotherapy (NACT) … HE4 and CA125 during first-line
chemotherapy. Our results suggest that monitoring HE4 and CA125 during first-line chemotherapy …

… Pre-chemotherapy and pre-IDS CA125, HE4 and CT response were used to calculate … to
determine the optimal threshold of HE4 levels and CA125 levels for predicting optimal surgery. p…